- Report
- August 2025
- 185 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 199 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 191 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 182 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 196 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 183 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 199 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 181 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 195 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 183 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- August 2025
- 193 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- October 2025
- 250 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Report
- September 2025
- 250 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Report
- September 2025
- 250 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Report
- April 2025
- 175 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Report
- January 2025
- 175 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Report
- January 2025
- 72 Pages
Asia Pacific
From €2907EUR$3,250USD£2,557GBP
- Report
- July 2024
- 153 Pages
Global
From €4428EUR$4,950USD£3,895GBP
- Report
- December 2022
- 130 Pages
Global
From €5322EUR$5,950USD£4,681GBP
- Report
- January 2024
- 200 Pages
Global
From €3712EUR$4,150USD£3,265GBP

The Multiomics market is a subset of the Genomics market, focusing on the analysis of multiple types of omics data. This includes data from genomics, transcriptomics, proteomics, metabolomics, and epigenomics. Multiomics data can be used to gain a more comprehensive understanding of biological systems, such as the interactions between genes, proteins, and metabolites. This data can be used to develop new diagnostics, treatments, and therapies for a variety of diseases.
Multiomics technology is rapidly advancing, with new tools and techniques being developed to improve the accuracy and speed of data analysis. This technology is being used in a variety of industries, including healthcare, agriculture, and biotechnology.
Some companies in the Multiomics market include Illumina, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, and Bio-Rad Laboratories. Show Less Read more